First Trust Advisors »

Inhibrx Biosciences shares owned by First Trust Advisors

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by First Trust Advisors from 13F filings

Historical chart of First Trust Advisors investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by First Trust Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by First Trust Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $12M 128k 94.75

More positions owned by First Trust Advisors

Cisco Systems (CSCO)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Palo Alto Networks (PANW)
Applied Materials (AMAT)
Microsoft Corporation (MSFT)
Apple (AAPL)
Fortinet (FTNT)
Kla Corp Com New (KLAC)
Lam Research Corp Com New (LRCX)
Crowdstrike Hldgs Cl A (CRWD)
Quanta Services (PWR)
Eaton Corp SHS (ETN)
Micron Technology (MU)

View all positions for First Trust Advisors

Top funds holding Inhibrx Biosciences

Perceptive Advisors
Morgan Stanley
Sanofi
Viking Global Investors
HighTower Advisors
Bank of America Corporation
BlackRock
Schonfeld Strategic Advisors
State Street Corporation
Vanguard Capital Management
Goldman Sachs Group
Woodline Partners
Capital Research Global Investors
Partner Fund Management
Sofinnova Ventures

View all funds holding Inhibrx Biosciences